Preview

Diabetes mellitus

Advanced search

Endothelial function in men with type 2 diabetes without clinical signs of cardiovascular disease

https://doi.org/10.14341/DM8017

Abstract

Type 2 diabetes mellitus (T2DM) increases the risk of cardiovascular disease that is based on endothelial dysfunction (ED). Currently, conventional diagnostic methods are unreliable, especially at early stages of disease.

Aims. The aim of this work was to assess endothelial function in men with T2DM without clinical signs of cardiovascular disease.

Materials and methods. The study included 100 patients (mean age, 54.3 ± 5.3 years) with a T2DM duration of less than 10 years and without signs of cardiovascular disease. The patients were divided into two groups: group 1 consisted of 60 patients with a T2DM duration of less than five years. Group 2 included 40 men with a history of diabetes between 5 and 10 years. Endothelial function was assessed by the levels of nitric oxide (NO), endothelial NO synthase type 3 (eNOS3), ICAM-1, VCAM-1, E-selectin, P-selectin, resistin and C-reactive protein and the arterial vasoreactivity of the brachial artery (BA) using the D. Celermajer method.

Results. Results revealed decreases in levels of both eNOS3 by 2.5 fold (P = 0.0005) and NO by 1.9 fold (P = 0.043) in group 2 patients, compared to those in group 1 patients. When the duration of diabetes was greater than five years, levels of VCAM-1, resistin and C-reactive protein increased by 12.1% (P = 0.048), 62% (P = 0.01) and 45.6%, respectively. Additionally, the time until maximal BA vasodilatation during reactive hyperemia was observed to be higher in group 2 [105 (90; 180) seconds] than those in group 1 [90 (60; 120) seconds].

Conclusions. Biochemical and imaging signs of ED begin to appear in the first five years of T2DM, long before clinical manifestations. The earliest symptoms are decreases in eNOS3 and NO levels, increases in VCAM-1 and resistin concentrations and increased time until maximal BA vasodilatation during reactive hyperemia.

About the Authors

Irina Alexandrovna Khripun
Rostov State Medical University
Russian Federation
PhD, assosiate professor,Department of Endocrinology with the course of Pediatric Endocrinology
Competing Interests:

No conflict of interest



Sergey Vladislavovich Vorobyev
Rostov State Medical University
Russian Federation
PhD, assosiate professor,Department of Endocrinology with the course of Pediatric Endocrinology
Competing Interests: No conflict of interest


Maxim Nikolaevich Morgunov
Rostov State Medical University
Russian Federation
PhD, assistent of professor, Department of Ultrasound Diagnosis
Competing Interests: No conflict of interest


Michail Iosifovich Kogan
Rostov State Medical University
Russian Federation
PhD, professor, Department of Urology and Reproductive Health
Competing Interests: No conflict of interest


References

1. Дедов И.И., Шестакова М.В., Галстян Г.Р. Распространенность сахарного диабета 2 типа у взрослого населения России (исследование NATION) // Сахарный диабет. – 2016. – Т. 19. – №2 – C. 104-112. [Dedov II, Shestakova MV, Galstyan GR. The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study). Diabetes mellitus. 2016;19(2):104-112. (In Russ.)] doi: 10.14341/DM2004116-17

2. IDF Diabetes Atlas. 7-th edition. 2015. Available from: www.idf.org/diabetesatlas/7e/

3. Аметов А.С. Сахарный диабет 2 типа. Проблемы и решения. 3-еизд. – М.: ГЭОТАР-Медиа; 2015. [Ametov AS. Saharnyj diabet 2 tipa. Problemy i resheniya. 3d ed. – Moscow: GEHOTAR-Media; 2015. (In Russ.)]

4. Polovina MM, Potpara TS. Endothelial dysfunction in metabolic and vascular disorders. Postgrad Med. 2014;126(2):38-53. doi: 10.3810/pgm.2014.03.2739

5. Руководство по кардиологии в четырех томах. Том 2: Методы диагностики сердечно-сосудистых заболеваний. / Под ред. Е.И. Чазова. – М.: Практика; 2014. [Manual Cardiology in four volumes. Volume 2: Methods for diagnosing cardiovascular disease. / Ed. by Chazov E.I. Moscow: Praktika; 2014. (In Russ.)]

6. Tousoulis D, Kampoli A-M, Tentolouris Nikolaos Papageorgiou C, Stefanadis C. The Role of Nitric Oxide on Endothelial Function. Curr Vasc Pharmacol. 2012;10(1):4-18. doi: 10.2174/157016112798829760.

7. Förstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33(7):829-837. doi: 10.1093/eurheartj/ehr304

8. Ruggiero D, Paolillo S, Ratta GD, et al. Endothelial function as a marker of pre-clinical atherosclerosis: assessment techniques and clinical implications. Monaldi Arch. Chest. Dis. 2013;80 (3):106-110.

9. Хрипун И.А., Гусова З.Р., Ибишев Х.С., и др. Эндотелиальная дисфункция у мужчин – взгляд клинициста (обзор литературы) // Бюллетень сибирской медицины. – 2014. – Т. 13. – №5 – С.169-178. [Khripun IA, Gusova ZR, Ibishev HS, et al. Endothelial dysfunction in men – a clinical view (literature review). Bulletin of Sibirian medicine. 2014;13(5):169-178.]

10. Charakida M, Masi S, Luscher TF, et al. Assessment of atherosclerosis: the role of flow-mediated dilatation. Eur Heart J. 2010;31(23):2854-2861. doi: 10.1093/eurheartj/ehq340

11. Harris RA, Nishiyama SK, Wray DW, Richardson RS. Ultrasound assessment of flow-mediated dilation. Hypertension. 2010;55(5):1075-1085. doi: 10.1161/HYPERTENSIONAHA.110.150821

12. Bonetti PO. Endothelial Dysfunction: A Marker of Atherosclerotic Risk. Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;23(2):168-175. doi: 10.1161/01.atv.0000051384.43104.fc

13. Arrebola-Moreno AL, Laclaustra M, Kaski JC. Noninvasive assessment of endothelial function in clinical practice. Rev Esp Cardiol (Engl Ed). 2012;65(1):80-90. doi: 10.1016/j.recesp.2011.09.012

14. Хрипун И.А., Моргунов М.Н., Воробьев С.В., и др. Способ отбора пациентов с сахарным диабетом 2 типа в группу риска по развитию эндотелиальной дисфункции. Решение о выдаче патента регистрационный номер 2015140824/14(062888) от 02.11.2016. [Khripun IA, Morgunov MN, Vorobyev SV, et al. A screening method of patients with type 2 diabetes at risk for the development of endothelial dysfunction. Reshenie o vidache patenta registratsionnyiy nomer 2015140824/14(062888) ot 02.11.2016. (in Russ.)]

15. Kelly DM, Jones TH. Testosterone and cardiovascular risk in men. Front Horm Res. 2014;43:1-20. doi: 10.1159/000360553

16. Хрипун И.А., Воробьев С.В., Пузырева В.П. и др. Дисфункция эндотелия как следствие андрогенного дефицита у мужчин с сахарным диабетом 2 типа. // Современные проблемы науки и образования. – 2015. – № 6 – С. 220. [Khripun IA, Vorobyev SV, Puzyireva VP, etal. Dysfunction of endothelium, as a result of androgen deficiency in men with type 2 diabetes. Sovremennyie problemy nauki i obrazovaniya. 2015;(6):220. (In Russ.)]

17. Tirabassi G, Cignarelli A, Perrini S, et al. Influence of CAG Repeat Polymorphism on the Targets of Testosterone Action. Int J Endocrinol. 2015;2015:298107. doi: 10.1155/2015/298107

18. Хрипун И.А., Воробьев С.В., Коган М.И. Взаимосвязь полиморфизма гена рецептора андрогенов и функции эндотелия у мужчин с сахарным диабетом 2 типа // Сахарный диабет. – 2015. – Т. 18. – №4 – C. 35-40. [Khripun IA, Vorobyev SV, Kogan MI. Association of the polymorphism in the androgen receptor gene and endothelial function in men with type 2 diabetes. Diabetes mellitus. 2015;18(4):35-40. (In Russ)] doi: 10.14341/DM7622


Supplementary files

Review

For citations:


Khripun I.A., Vorobyev S.V., Morgunov M.N., Kogan M.I. Endothelial function in men with type 2 diabetes without clinical signs of cardiovascular disease. Diabetes mellitus. 2016;19(5):383-387. (In Russ.) https://doi.org/10.14341/DM8017

Views: 681


ISSN 2072-0351 (Print)
ISSN 2072-0378 (Online)